Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Guardant Health revenue
Guardant Health's revenue is $739.0 million.
What is Guardant Health's revenue?
- Guardant Health's revenue growth from 2017 to 2024 is 1,382.72%.
- Guardant Health has 500 employees, and the revenue per employee ratio is $1,478,032.
- Guardant Health's peak quarterly revenue was $201.8M in 2024(q4).
- Guardant Health peak revenue was $739.0M in 2024.
- Guardant Health annual revenue for 2023 was 563.9M, 25.45% growth from 2022.
- Guardant Health annual revenue for 2024 was 739.0M, 31.04% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Guardant Health historical revenue
Guardant Health's peak revenue was $739.0M in 2024. The peak quarterly revenue was $201.8M in 2024(q4).
Guardant Health's revenue increased from $49.8m in 2017 to $739.0M currently. That's a 1,382.72% change in annual revenue.
Guardant Health annual revenue
Guardant Health annual revenue over time
| Fiscal year / year | Guardant Health revenue |
|---|---|
| 2017 | $49.8M |
| 2018 | $90.6M |
| 2019 | $214.4M |
| 2020 | $286.7M |
| 2021 | $373.7M |
| 2022 | $449.5M |
| 2023 | $563.9M |
| 2024 | $739.0M |
Rate Guardant Health's financial transparency
Guardant Health annual growth
Guardant Health saw the greatest revenue growth in 2019, when revenue increased by 136.52%.
Guardant Health had the lowest revenue growth in 2022, when revenue changed by 20.31%.
Guardant Health annual growth rate over time
| Year | Guardant Health growth |
|---|---|
| 2018 | 82%↑ |
| 2019 | 137%↑ |
| 2020 | 34%↑ |
| 2021 | 30%↑ |
| 2022 | 20%↑ |
| 2023 | 25%↑ |
| 2024 | 31%↑ |
Guardant Health quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Guardant Health quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | $21.7M | $32.9M |
| 2019 | $36.7M | $54.0M | $60.8M | $62.9M |
| 2020 | $67.5M | $66.3M | $74.6M | $78.3M |
| 2021 | $78.7M | $92.1M | $94.8M | $108.1M |
| 2022 | $96.1M | $109.1M | $117.4M | $126.9M |
| 2023 | $128.7M | $137.2M | $143.0M | $155.1M |
| 2024 | $168.5M | $177.2M | $191.5M | $201.8M |
Guardant Health jobs nearby
Do you work at Guardant Health?
Is Guardant Health transparent about its revenue structure?
Guardant Health financial information
| CEO | Helmy Eltoukhy |
| Industry | Software & Services |
| Company Type | Public |
| Employees Number | 500 |
| Date Founded | 2012 |
| Headquarters | Redwood City, California |
| Number of Locations | 3 |
| Revenue | $739.0M |
| Net Income | -$654,588,000 |
| Gross Proft | $449.2M (2024) |
| Tax Rate | -0.0% |
| Total Assets | $1,609,985,000 |
| Ticker | GH |
Guardant Health jobs you might like
Guardant Health financing
Guardant Health received early financing of $10.0M on 2014-02-11.
| Series | Round size | Date |
|---|---|---|
| Series A | $10M | 02/2014 |
| Series B | $30M | 04/2014 |
| Series C | $50M | 02/2015 |
| Series D | $100M | 01/2016 |
| Series E | $360M | 05/2017 |
Guardant Health investors
| Investors | Security type |
|---|---|
| Farzad Nazem | Series A |
| Cota Capital | Series A |
| OUP (Osage University Partners) | Series A |
| Sequoia Capital | Series A |
| Frank Malek | Series A |
| Pear VC | Series B |
| Signatures Capital | Series B |
| Sequoia Capital | Series B |
| Khosla Ventures | Series B |
| SGH CAPITAL | Series C |
| Formation 8 | Series C |
| Lightspeed Venture Partners | Series C |
| Sequoia Capital | Series C |
| Felicis Ventures | Series C |
| Khosla Ventures | Series C |
| Pear VC | Series D |
| Hone Capital | Series D |
| Formation 8 | Series D |
| OrbiMed | Series D |
| Heritage Group | Series D |
| Lightspeed Venture Partners | Series D |
| Sequoia Capital | Series D |
| Felicis Ventures | Series D |
| Khosla Ventures | Series D |
| Laszlo Bock | Series D |
| SoftBank Vision Fund | Series E |
| 8VC | Series E |
| OrbiMed | Series E |
| Temasek Holdings | Series E |
| Lightspeed Venture Partners | Series E |
| T. Rowe Price | Series E |
| Sequoia Capital | Series E |
| Khosla Ventures | Series E |
| C.M. Capital Advisors | Series E |
Guardant Health competitors
Guardant Health's top competitor, Illumina, earned an annual revenue of $4.4B.
Guardant Health's smallest competitor is Capio Biosciences with revenue of $80.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cynvenio Biosystems | - | $1.6M | 11 | - |
| Resolution Bioscience | - | $9.2M | 175 | - |
| Capio Biosciences | - | $80,000 | 5 | - |
| Perthera | - | $8.0M | 28 | - |
| NAVERIS | - | $440,000 | 19 | - |
| nference | - | $5.0M | 350 | - |
| Illumina | - | $4.4B | 7,800 | - |
| Foundation Medicine | - | $152.9M | 1,300 | - |
| Genentech | - | $166.9M | 13,638 | - |
| Natera | - | $820.2M | 975 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Guardant Health highest paying jobs
Zippia gives an in-depth look into the details of Guardant Health, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Guardant Health. The employee data is based on information from people who have self-reported their past or current employments at Guardant Health. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Guardant Health. The data presented on this page does not represent the view of Guardant Health and its employees or that of Zippia.
Guardant Health may also be known as or be related to GUARDANT HEALTH, INC., Guardant Health and Guardant Health, Inc.